NIH VideoCast - NIH Director's Seminar: Developing novel immunotherapy strategies for HPV-associated respiratory papillomatosis

Skip Navigation

NIH Director's Seminar: Developing novel immunotherapy strategies for HPV-associated respiratory papillomatosis

Loading... Loading video...

136 Views

Air date:	Friday, March 17, 2023, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 136 (113 Live, 23 On-demand)
Category:	NIH Director's Seminars
Runtime:	01:01:26
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Recurrent respiratory papillomatosis (RRP) is a rare disorder that manifests as progressively growing aerodigestive tract papillomas that cause profound voice disturbance and airway obstruction. The disorder is caused by chronic infection with HPV type 6 or 11. One research interest of the Allen lab is to develop and study novel, rationally designed therapeutic approaches for RRP. In this lecture, Dr. Allen will highlight newly identified mechanisms of immune escape utilized by HPV6 or 11 to escape innate and adaptive immunity and discuss the results of prospective immunotherapy clinical trials conducted at the NIH Clinical Center for this disease.

NLM Title:	Developing novel immunotherapy strategies for HPV-associated respiratory papillomatosis / Clint Allen.
Author:	Allen, Clint. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): Recurrent respiratory papillomatosis (RRP) is a rare disorder that manifests as progressively growing aerodigestive tract papillomas that cause profound voice disturbance and airway obstruction. The disorder is caused by chronic infection with HPV type 6 or 11. One research interest of the Allen lab is to develop and study novel, rationally designed therapeutic approaches for RRP. In this lecture, Dr. Allen will highlight newly identified mechanisms of immune escape utilized by HPV6 or 11 to escape innate and adaptive immunity and discuss the results of prospective immunotherapy clinical trials conducted at the NIH Clinical Center for this disease.
Subjects:	Human papillomavirus 31--pathogenicity Immunotherapy Papilloma--immunology Papilloma--therapy Respiratory Tract Neoplasms--immunology
Publication Types:	Lecture Webcast
NLM Classification:	WF 450
NLM ID:	9918592672606676
CIT Live ID:	49341
Permanent link:	https://videocast.nih.gov/watch=49341

Related Videos...